An article on Phys.org talks about the next generation in medicine and biofuels can come from the ocean’s floors. Given that in the last few years the number of antibiotic resistant bacteria and/or diseases have gone up, it’s no wonder that mining the world’s oceans is the next step for humanity.

“The reason why this line of research is so critical is because antibiotic resistance is a serious threat to human health,” said Margo Haygood, Ph.D., a member of the OHSU Institute of Environmental Health and a professor of science and engineering in the OHSU School of Medicine.

OHSU researchers, in partnership with scientists from several other institutions, have published two new research papers that signal how the next class of powerful medications may currently reside at the bottom of the ocean. In both cases, the researchers were focused on ocean-based mollusks – a category of animal that includes snails, clams and squid and their bacterial companions.

Sea life studies aid researchers in several ways, including the development of new medications and biofuels, look at the newest testosterone booster medication tech reviews. Because many of these ocean animal species have existed in harmony with their bacteria for millions of years, these benign bacteria have devised molecules that can affect body function without side effects and therefore better fight disease. To generate these discoveries, a research partnership called the Philippine Mollusk Symbiont International Cooperative Biodiversity Group was formed. As the name suggests, the group specifically focuses on mollusks, a large phylum of invertebrate animals, many of which live under the sea. Margo Haygood, Ph.D., an OHSU marine microbiologist, leads the group, with partners at the University of the Philippines, the University of Utah, The Academy of Natural Sciences in Philadelphia and Ocean Genome Legacy. Both of these newly published papers are the result of the efforts of this research group.

Read more at: Phys.org

Full source: Mother Jones

The Pew Charitable Trusts crunched the agency’s numbers on antibiotic use on livestock farms and compared them to data on human use of antibiotics to treat illness, and mashed it all into an infographic, which I’ve excerpted below. Note that that while human antibiotic use has leveled off at below 8 billion pounds annually, livestock farms have been sucking in more and more of the drugs each year—and consumption reached a record nearly 29.9 billion pounds in 2011. To put it another way, the livestock industry is now consuming nearly four-fifths of the antibiotics used in the US, and its appetite for them is growing.